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PreviewsInterestingly, the effect of antibiotic
treatment was limited to two nonadju-
vated vaccines, TIV and another viral
subunit vaccine to polio. In contrast, im-
munization with alum-absorbed toxoids,
the HIVenv protein as well as a live-atten-
uated yellow fever vaccine, were unaf-
fected. Thus, the microbiota has no
detectable effect on the induced humoral
response to adjuvanted vaccines or
attenuated pathogens. Flagellin has long
been known to represent a potent immu-
nostimulatory molecule and useful adju-
vant. The presented data now reveal an
unexpected role of naturally produced
flagellin derived from the microbiota to
provide costimulation for immune activa-
tion. Thus, the intestinal microbiota might
effectively take the function of a natural
adjuvant. This view is consistent with les-
sons learned from gut immunology: the
microbiota is an essential driver of ho-meostasis and a key part of an effective
immune system.REFERENCES
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Proinflammatory macrophage activation is coupled to a metabolic switch toward glycolysis. In Cell Meta-
bolism, Jin et al. (2014) show that this process is negatively regulated by mitochondrial electron transport
chain complex I through both cell intrinsic and extrinsic pathways.There is a link between anti-inflammatory
properties and mitochondrial oxidative
phosphorylationontheonehand,andclas-
sical activation and glycolytic metabolism
on the other (O’Neill and Hardie, 2013). In
their recent paper in Cell Metabolism, Jin
and colleagues highlight the importance
of complex I (CI) in regulating macrophage
activation by showing that deletion of the
CI component Ndufs4 causes a switch in
the metabolic balance toward glycolysis
and associated changes in the monocyte,
macrophage, and osteoclast lineage that
result in the development of inflammatory
disease symptoms and abnormal bone
density (Jin et al., 2014).
The electron transport chain (ETC),
which links nutrient oxidation to ATPproduction by oxidative phosphorylation
(OXPHOS), consists of complexes I–V
in the mitochondrial inner membrane
(Figure 1). CI is composed of >45 sub-
units and is highly regulated by path-
ways initiated by various extracellular
signals (Papa et al., 2012). Unsurpris-
ingly, mutations in genes encoding com-
ponents of CI are associated with severe
clinical disease (Papa et al., 2012). From
an immunologic perspective, CI is inter-
esting not only because of its core func-
tion in metabolism but because along
with complex III, it is a site of reactive
oxygen species (ROS) production (Sena
and Chandel, 2012). ROS plays a role
in a range of innate cell functions, and
indeed Toll-like receptor (TLR) signalinghas been linked to increased production
of mitochondrial ROS for bacterial killing
(Sena and Chandel, 2012). However,
ROS can be detrimental when produced
in excess, and this can occur when CI
function is compromised (Chen et al.,
2007).
Ndufs4/ mice have been used to
model CI deficiency and have been found
to die from encephalomyopathy approxi-
mately 7 weeks after birth (Kruse et al.,
2008). Using these mice, Jin and col-
leagues discovered that by 3 weeks
after birth, the absence of Ndufs4 led
to systemic inflammation, apparent as
increased levels of proinflammatory cyto-
kines, systemically increased numbers of
Ly6chi monocytes and the developmentptember 18, 2014 ª2014 Elsevier Inc. 351
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Figure 1. Loss of CI Function Has Cell-Intrinsic and -Extrinsic Effects on Macrophages and
Osteoclasts
Ndufs4 is a critical component of complex I (CI), which is part of the electron transport chain (ETC) that is
responsible for creating the proton gradient that is used to generate ATP by oxidative phosphorylation
(OXPHOS). This pathway, supported by the oxidation of glucose and fatty acids (FAs), is utilized by resting
macrophages and by osteoclasts. Deletion of Ndufs4 in macrophages results in the inhibition of OXPHOS
and a commitment to aerobic glycolysis to meet ATP demands. Under these conditions, CI, which is a site
of physiologic ROS production, becomes a site of excessive ROS generation. These processes are
accompanied by the expression of inflammatory genes. Deletion of Ndufs4 in hematopoietic precursors
results in a relative failure of osteoclast differentiation in response to RANKL and MCSF and the diversion
of monocytes toward the macrophage lineage. The situation is compounded when Ndufs4 is deleted in
other tissues such as liver. In this case, plasma levels of lactic acid, triacylglycerols, and free FAs increase,
and the expression of inflammatory mediators by macrophages is exacerbated and the differentiation of
osteoclasts is inhibited in a cell-extrinsic manner. These processes are dependent on TLR4 and/or ROS.
Endogenous FA might be TLR agonists in this context, but other stimuli have not been ruled out. The
mechanism of action of lactic acid to promote macrophage activation and diminish osteoclast differenti-
ation in Ndufs4/ mice is unknown at present.
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Previewsof alopecia with macrophage skin infiltra-
tion. A component of this response was
macrophage intrinsic, because macro-
phages grown from Ndufs4/ bone
marrow expressed inflammatory genes
more strongly and anti-inflammatory
genes less strongly in the steady state
than did wild-type (WT) macrophages.
Moreover, macrophages from Lyz2-cre-
Ndufs4fl/fl mice and Tek-cre-Ndufs4fl/fl
mice, in which Ndufs4 deletion was
restricted to monocytes and macro-
phages or cells of hematopoietic origin,
respectively, also exhibited increased
baseline expression of inflammatory
genes. Nevertheless, these mice did not
exhibit the skin disorder or monocyte
and macrophage imbalances or early
lethality of Ndufs4/ mice. This finding
led the authors to look for macrophage
extrinsic factors that could contribute to352 Immunity 41, September 18, 2014 ª2014the complex pathologic changes in the
Ndufs4/ animals.
Human cases of CI deficiency are
marked by lactic acidosis, which reflects
the fact that cells lacking functional CI
have to utilize aerobic glycolysis to make
ATP, and the major end product of this
pathway is lactic acid (Figure 1). Jin and
colleagues found that Ndufs4/ mice
also had elevated serum lactate levels,
along with elevated serum triglycerides
and free fatty acids (FAs) (Figure 1). The
changes in lipids are consistent with the
reported inhibitory effects of loss of CI
function on mitochondrial FA oxidation
(Leong et al., 2012) (Figure 1). Elevated
serum lipids were not apparent in Tek-
cre-Ndufs4fl/fl mice but were apparent in
Alb-cre-Ndufs4fl/fl mice, in which Ndufs4
was deleted in hepatocytes. The authors
reasoned that the inability of the liverElsevier Inc.(and other organs) to oxidize FAs in the
absence of Ndufs4 and resultant in-
creases in plasma triacylglycerols and
free FAs could be a contributing extrinsic
factor to the more aggressive pathologic
features in whole body compared to con-
ditional knockouts, because in type 2 dia-
betes and atherosclerosis, for example,
elevated plasma triacylglycerols and free
FAs are associated with inflammation. In
these settings, inflammation and disease
can be ameliorated by deletion of TLR2
and/or TLR4 (discussed in Erridge and
Samani, 2009). In this vein, the authors
found that the gross inflammatory condi-
tions in Ndufs4/mice were significantly
diminished in Ndufs4,Tlr2,Tlr4/ mice
even though serum FAs, triglycerides,
and lactic acid remained elevated. Fur-
thermore, the targeting of TLR4 with a
chemical inhibitor was able to prevent at
least one of the consequences of Ndufs4
deficiency—alopecia.
In addition to documenting the effects
of loss of CI function on macrophage
biology, Jin et al. examined CI biology
in osteoclasts. These cells, which like
macrophages can also differentiate from
monocytes, are responsible for bone
resorption. Differentiation to osteoclasts
is associated with mitochondrial biogen-
esis and increased oxidative metabolism.
Consistent with this, bone density was
greater in Ndufs4/ mice than in WT
mice. This was partially due to mono-
cyte-intrinsic effects of the loss of Ndufs4
on osteoclast differentiation but was
exacerbated by central metabolic pro-
cesses in the liver, because changes in
bone density were apparent in Alb-cre-
Ndufs4fl/fl, as well as in Tek-cre-Ndufs4fl/fl
mice, and were exacerbated when
Ndufs4 was deleted in both osteoclasts
and hepatocytes (Figure 1). Deletion of
Ndufs4 in osteoclasts or hepatocytes
had the powerful effect of preventing the
development of LPS-induced experi-
mental arthritis and bone loss despite
the fact that inflammatory gene expres-
sion was exacerbated, indicating that,
depending on context, loss of CI activity
can have pronounced beneficial effects.
This work establishes the importance of
CI in maintaining metabolic hemostasis in
monocyte-derived cells. It emphasizes
the balance between OXPHOS and aero-
bic glycolysis in the biology of these cells
and indicates that facets of disease due to
CI deficiency in people might reflect
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Previewsalterations inmacrophage biology that are
amenable to therapeutic targeting of TLR
signaling. Further, it addresses the issue
of whether changes in metabolism are
merely reflective of changes in cellular
activation or rather play an initiating role
in these processes; the fact that inhibiting
OXPHOS was able to prime macrophage
activation in a cell-autonomous fashion
provides strong support for the latter
view. In this regard, this study makes
intriguing and valuable contributions to
our understanding of macrophage and
osteoclast biology. However, as with
many complex and wide-ranging studies,
some interesting findings remained less
deeply explored than others. Of particular
interest here is the identity of the macro-
phage and osteoclast extrinsic signals
that alter the biology of these cells in
Ndufs4/ mice and which appear to
require TLR2 and/or TLR4.What are these
exactly? The authors found that lactic
acid, as well as palmitic and linoleic FAs,
were able to activate macrophages and
inhibit osteoclast differentiation in vivo
and/or in vitro. However, while there has
been considerable historic interest in the
possibility that endogenous lipid species
act directly as agonists for TLRs, this
scenario is now questioned (Erridge and
Samani, 2009). Other possible endoge-
nous TLR agonists have emerged, such
as the damage-associated molecular
pattern molecule high-mobility group
box 1 (HMGB1), and in other settings
where plasma fats are elevated LPS
from commensal bacteria has been
implicated in promoting TLR4-dependent
inflammation (discussed in Erridge and
Samani, 2009). It is conceivable that
Ndufs4 deletion could result in changes
in HMGB1 release and/or in barrier
epithelial integrity leading to low-grade
endotoxemia, either of which might affect
macrophage or osteoclast biology. Withregard to lactic acid, Jin et al. are not the
first to show a proinflammatory effect of
this metabolite on macrophages, but
these findings contrast with recently pub-
lished data showing that lactic acid
induces the expression of alternative acti-
vation markers that are linked to the regu-
lation of inflammation (Colegio et al.,
2014). It will be important to deconvolute
this area because concentrations of lactic
acid vary not only due to metabolic dis-
ease but also as a result of cancers and in-
fections, and understanding the effects of
this metabolite on macrophages and
related cells might provide clues for the
development of relevant therapeutics.
Consistent with the known importance
of CI in ROS production, Ndufs4/ mice
exhibited evidence of increased ROS pro-
duction in all tissues examined.Moreover,
Ndufs4/ macrophages made signifi-
cantly more ROS at baseline than did
WT macrophages and were induced to
make additional ROS by palmitic acid.
Consistent with the damaging effects of
excessive ROS, Ndufs4/ macrophages
expressed the stress sensors Gadd45a/b
and were more apoptotic. In patients with
tumor necrosis factor receptor (TNFR)-
associated periodic syndrome, excessive
ROS sensitizes TLR4 signaling (Sena and
Chandel, 2012), and it is tempting to
conclude that a similar situation exists
in Ndufs4/ macrophages. However, a
thought at least should be given to the
possibility that the NLRP3 inflammasome
is involved in the inflammatory conse-
quences of loss of CI function. This innate
sensor is localized to mitochondria and is
activated by ROS (Sena and Chandel,
2012) and is able to initiate interleukin-1b
(IL-1b) activation, which is then able to
further activate macrophages to make
additional inflammatory cytokines. The
downstream inflammatory consequences
of this pathway would be expected to beImmunity 41, Sesimilar to those reported in the paper.
This is particularly intriguing in light of
the report that palmitic acid is able to acti-
vate the NLRP3 inflammasome through a
ROS-dependent pathway (Wen et al.,
2011).
In summary, the paper by Jin et al. pro-
vides insights into the role of CI at the
interface between metabolism and immu-
nity and provides further support for anti-
inflammatory effects of OXPHOS. Indeed,
in certain cases it seems that Ndufs is
enough to prevent the emergence of life-
threatening inflammation.REFERENCES
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